Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo 1H-MRS studies
Open Access
- 22 June 2024
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 199, 106574
Abstract
No abstract availableKeywords
Funding Information
- China Scholarship Council
This publication has 93 references indexed in Scilit:
- Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's DiseaseMovement Disorders, 2022
- Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington’s diseaseFEBS Open Bio, 2021
- Tracking Huntingtonʼs Disease Progression Using Motor, Functional, Cognitive, and Imaging MarkersMovement Disorders, 2021
- Computing effect sizes for meta‐analysis2015
- Brain metabolite alterations and cognitive dysfunction in early Huntington's diseaseMovement Disorders, 2012
- Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: A 1H‐MRS studyMagnetic Resonance in Medicine, 2008
- Evidence of thalamic dysfunction in Huntington disease by proton magnetic resonance spectroscopyMovement Disorders, 2007
- A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI‐cycle) to psychiatric disorders—focus on magnetic resonance spectroscopy (MRS) studiesHuman Psychopharmacology: Clinical and Experimental, 2005
- Riluzole therapy in Huntington's disease (HD)Movement Disorders, 1999
- Proton magnetic resonance spectroscopy in Huntington's disease: Evidence in favour of the glutamate excitotoxic theory?Movement Disorders, 1996